Q2 FY26 Results: Revenue up 20% YoY at Rs 1,998 mn; PAT at Rs 504 mn

Revenue growth above 20%EBITDA margin compressionResults View source PDF Explain this filing

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹763.00

prior close

₹774.95

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%+3.0% vs market

Pharmaceuticals peers, median of 157sector-0.1%+3.0% vs sector

On the reaction day the stock moved 3.0 pts more than Nifty Microcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

+0.5

15m

+1.3

30m

+2.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9-0.1+3.0-0.1+3.0

Next day

+3.1-0.2+3.3-0.5+3.6

+3.2+0.4+2.8-0.4+3.6

+4.6-0.4+5.0-1.1+5.7

+1.5-0.6+2.1-1.4+2.9

+1.0-0.9+1.9-1.6+2.6

-2.4-3.0+0.6-3.3+1.0

15d

-2.2-3.9+1.7-3.4+1.2

-5.4-4.8-0.5-4.0-1.3

-3.5-7.8+4.2-6.9+3.3

-10.8-7.2-3.5-8.5-2.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Supriya Lifescience Q2 FY26 revenue rose 20.3% YoY to Rs 1,998.33 mn; PAT grew 9.3% to Rs 504.27 mn (EPS Rs 6.27). H1 FY26 revenue up 5.6% at Rs 3,449.07 mn but PAT fell 6.1% to Rs 852.17 mn. Margins compressed as employee costs and other expenses rose faster than revenue. Board approved results on Nov 12, 2025; auditor Kakaria and Associates issued an unqualified review report.

Likely market impact

Strong Q2 revenue growth but margin pressure and weak H1 PAT suggest mixed near-term outlook for the stock.